changjiang pharmaceutical group (300391.SZ): net loss of 0.181 billion yuan in the first three quarters.

Gelonghui Finance · Oct 29 23:41

On October 29, Gelonhui reported that Changjiang Pharmaceutical Group (300391.SZ) released its third quarter report for 2024, achieving revenue of 0.101 billion yuan in the first three quarters of the year, a year-on-year decrease of 90.12%; net income attributable to the shareholders of the listed company was -0.181 billion yuan; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was -0.179 billion yuan; basic earnings per share was -0.5166 yuan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

长药控股(300391.SZ)：前三季度净亏损1.81亿元

changjiang pharmaceutical group (300391.SZ): net loss of 0.181 billion yuan in the first three quarters.

Risk Disclaimer

Statement